{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:38:11Z","timestamp":1772793491419,"version":"3.50.1"},"reference-count":87,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2017.00008","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T22:33:18Z","timestamp":1485383598000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Novel Immunotherapies for Autoimmune Hepatitis"],"prefix":"10.3389","volume":"5","author":[{"given":"Shamir","family":"Cassim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Bilodeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Lapierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1237","DOI":"10.1542\/peds.2015-0578","article-title":"Incidence and characteristics of autoimmune hepatitis","volume":"136","author":"Jimenez-Rivera","year":"2015","journal-title":"Pediatrics"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"B3","first-page":"429","article-title":"Autoimmune hepatitis","volume-title":"Liver Disease in Childhood","author":"Alvarez","year":"2001"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0022-3476(86)80880-0","article-title":"Liver disease associated with anti-liver-kidney microsome antibody in children","volume":"108","author":"Maggiore","year":"1986","journal-title":"J Pediatr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00005176-199311000-00007","article-title":"Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents","volume":"17","author":"Maggiore","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/0896-8411(91)90180-K","article-title":"Identification of the main epitope on human cytochrome P450 IID6 recognized by anti-liver kidney microsome antibody","volume":"4","author":"Gueguen","year":"1991","journal-title":"J Autoimmun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/eji.1830230519","article-title":"Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1)","volume":"23","author":"Yamamoto","year":"1993","journal-title":"Eur J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/hep.1840160407","article-title":"Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis","volume":"16","author":"Abuaf","year":"1992","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S0168-8278(99)80065-8","article-title":"Short-term cyclosporine induces a remission of autoimmune hepatitis in children","volume":"30","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/01.mpg.0000235975.75120.38","article-title":"Follow-up of children with autoimmune hepatitis treated with cyclosporine","volume":"43","author":"Cuarterolo","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1347.e","DOI":"10.1016\/j.jpeds.2013.05.042","article-title":"Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents","volume":"163","author":"Woynarowski","year":"2013","journal-title":"J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM199604043341406","article-title":"Autoimmune hepatitis","volume":"334","author":"Krawitt","year":"1996","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","author":"Cook","year":"1971","journal-title":"Q J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/hep.1840030510","article-title":"Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis","volume":"3","author":"Hegarty","year":"1983","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0168-8278(00)00095-7","article-title":"Duration of immunosuppressive therapy in autoimmune hepatitis","volume":"34","author":"Kanzler","year":"2001","journal-title":"J Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"van Gerven","year":"2013","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jhep.2014.10.018","article-title":"Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis","volume":"62","author":"Hartl","year":"2015","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/hep.510240619","article-title":"Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis","volume":"24","author":"Lohr","year":"1996","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/0140-6736(90)93306-A","article-title":"T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis","volume":"336","author":"Wen","year":"1990","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1084\/jem.182.5.1223","article-title":"Involvement of the CD95 (APO-1\/Fas) receptor and ligand in liver damage","volume":"182","author":"Galle","year":"1995","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1053\/jhep.2000.18422","article-title":"Induction of murine hepatocyte death by membrane-bound CD95 (Fas\/APO-1)-ligand: characterization of an in vitro system","volume":"32","author":"Schlosser","year":"2000","journal-title":"Hepatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/hep.510310317","article-title":"Fas- and tumor necrosis factor receptor 1-dependent but not perforin-dependent pathways cause injury in livers infected with an adenovirus construct in mice","volume":"31","author":"Liu","year":"2000","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.4049\/jimmunol.167.10.5928","article-title":"Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor\/myeloid differentiation factor 88-dependent mechanism","volume":"167","author":"Adachi","year":"2001","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.20504","article-title":"Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection","volume":"41","author":"Abougergi","year":"2005","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/hep.20566","article-title":"NFkappaB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis","volume":"41","author":"Zender","year":"2005","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1053\/gast.2002.36058","article-title":"Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8 T-cell activation by bone marrow-derived cells","volume":"123","author":"Bowen","year":"2002","journal-title":"Gastroenterology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/hep.26023","article-title":"Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance","volume":"57","author":"Lapierre","year":"2013","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/hep.23536","article-title":"Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis","volume":"51","author":"Lapierre","year":"2010","journal-title":"Hepatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/liv.12498","article-title":"Low-dose anti-CD3 antibody induces remission of active autoimmune hepatitis in xenoimmunized mice","volume":"35","author":"Marceau","year":"2015","journal-title":"Liver Int"},{"key":"B36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaut.2005.11.001","article-title":"Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development","volume":"26","author":"Lapierre","year":"2006","journal-title":"J Autoimmun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.20109","article-title":"A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens","volume":"39","author":"Lapierre","year":"2004","journal-title":"Hepatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1056\/NEJMoa012864","article-title":"Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus","volume":"346","author":"Herold","year":"2002","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/PPO.0000000000000035","article-title":"Managing cytokine release syndrome associated with novel T cell-engaging therapies","volume":"20","author":"Maude","year":"2014","journal-title":"Cancer J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/hep.27991","article-title":"Depletion of B cells induces remission of autoimmune hepatitis in mice through reduced antigen presentation and help to T cells","volume":"62","author":"Beland","year":"2015","journal-title":"Hepatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1542\/peds.2011-1900","article-title":"Successful treatment of refractory autoimmune hepatitis with rituximab","volume":"132","author":"D\u2019Agostino","year":"2013","journal-title":"Pediatrics"},{"key":"B42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy","volume":"27","author":"Burak","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/qjmed\/hcq152","article-title":"TNF-alpha antagonists beyond approved indications: stories of success and prospects for the future","volume":"103","author":"Karampetsou","year":"2010","journal-title":"QJM"},{"key":"B44","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J Hepatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2013.05.046","article-title":"Infliximab as rescue therapy in paediatric autoimmune hepatitis","volume":"59","author":"Rajanayagam","year":"2013","journal-title":"J Hepatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1038\/ajg.2009.433","article-title":"A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade","volume":"104","author":"Weiler-Normann","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-2008-1040319","article-title":"Bacterial infections, sepsis, and multiorgan failure in cirrhosis","volume":"28","author":"Tandon","year":"2008","journal-title":"Semin Liver Dis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"7584","DOI":"10.3748\/wjg.v21.i24.7584","article-title":"Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: a single center report of 8 cases","volume":"21","author":"Rodrigues","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.crohns.2012.01.017","article-title":"Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease","volume":"6","author":"van Casteren-Messidoro","year":"2012","journal-title":"J Crohns Colitis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/ajd.12054","article-title":"Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis","volume":"55","author":"Dang","year":"2014","journal-title":"Australas J Dermatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jaut.2016.05.005","article-title":"CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease","volume":"72","author":"Liberal","year":"2016","journal-title":"J Autoimmun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/hep.27884","article-title":"In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression","volume":"62","author":"Liberal","year":"2015","journal-title":"Hepatology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/hep.26583","article-title":"Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis","volume":"59","author":"Grant","year":"2014","journal-title":"Hepatology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"Hepatology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J Hepatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J Hepatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":"Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells","volume":"37","author":"Wang","year":"2007","journal-title":"Eur J Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","article-title":"CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis","volume":"183","author":"Fletcher","year":"2009","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/hep.24153","article-title":"Autoimmune hepatitis and antigen-specific T regulatory cells: when can we send in the regulators?","volume":"53","author":"Vierling","year":"2011","journal-title":"Hepatology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/hep.24039","article-title":"Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis","volume":"53","author":"Longhi","year":"2011","journal-title":"Hepatology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1053\/j.gastro.2012.02.041","article-title":"Inhibition of interleukin-17 promotes differentiation of CD25(-) cells into stable T regulatory cells in patients with autoimmune hepatitis","volume":"142","author":"Longhi","year":"2012","journal-title":"Gastroenterology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/hep.22071","article-title":"Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis","volume":"47","author":"Longhi","year":"2008","journal-title":"Hepatology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.4049\/jimmunol.0901216","article-title":"Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver","volume":"184","author":"Oo","year":"2010","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N Engl J Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1600-6143.2007.01736.x","article-title":"Cancer incidence among Canadian kidney transplant recipients","volume":"7","author":"Villeneuve","year":"2007","journal-title":"Am J Transplant"},{"key":"B69","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/00365521.2014.983154","article-title":"Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis \u2013 a long-term follow-up study in 634 Swedish patients","volume":"50","author":"Danielsson Borssen","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s10620-010-1444-6","article-title":"Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series","volume":"56","author":"Wong","year":"2011","journal-title":"Dig Dis Sci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1185\/03007995.2010.506375","article-title":"Population-based risk factors and resource utilization for HCC: US perspective","volume":"26","author":"Sanyal","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1200\/JCO.2013.51.4067","article-title":"Hepatocellular carcinoma regression after cessation of immunosuppressive therapy","volume":"34","author":"Kumar","year":"2016","journal-title":"J Clin Oncol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s10620-005-9009-9","article-title":"Hepatocellular carcinoma occurring in a patient with Crohn\u2019s disease treated with both azathioprine and infliximab","volume":"51","author":"Chen","year":"2006","journal-title":"Dig Dis Sci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12029-010-9158-8","article-title":"A case of explosive progression of hepatocellular carcinoma in a patient with common variable immunodeficiency (CVID)","volume":"41","author":"Gandhi","year":"2010","journal-title":"J Gastrointest Cancer"},{"key":"B79","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1159\/000444558","article-title":"Role of immunity in pathogenesis and treatment of hepatocellular carcinoma","volume":"34","author":"Schmidt","year":"2016","journal-title":"Dig Dis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/cid\/ciw380","article-title":"Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus-coinfected individuals from 2001 to 2014: a multicohort study","volume":"63","author":"Gjaerde","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B81","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s11864-012-0195-3","article-title":"Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients","volume":"13","author":"Bangash","year":"2012","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"B82","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-4245","article-title":"Two cases of hepatosplenic T-cell lymphoma in adolescents treated for autoimmune hepatitis","volume":"138","author":"Brinkert","year":"2016","journal-title":"Pediatrics"},{"key":"B83","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ajh.21753","article-title":"Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis","volume":"85","author":"Adams","year":"2010","journal-title":"Am J Hematol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11908-010-0145-9","article-title":"Posttransplant lymphoproliferative disease in liver transplant patients","volume":"13","author":"Hartmann","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/ajg.2012.89","article-title":"A pooled analysis of infections, malignancy, and mortality in infliximab- and immunomodulator-treated adult patients with inflammatory bowel disease","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jbspin.2010.11.012","article-title":"Rituximab in rheumatoid arthritis and the risk of malignancies: report from a French cohort","volume":"78","author":"Slimani","year":"2011","journal-title":"Joint Bone Spine"},{"key":"B87","doi-asserted-by":"publisher","first-page":"303A","DOI":"10.1002\/hep.26040","article-title":"Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9\u201313, 2012. Boston, Massachusetts, USA","volume":"56","author":"B\u00e9land","year":"2012","journal-title":"Hepatology"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2017.00008\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T22:33:18Z","timestamp":1485383598000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2017.00008\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":87,"URL":"https:\/\/doi.org\/10.3389\/fped.2017.00008","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,26]]}}}